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Chapter I 
INTR ODUCTI 00' 
i 
l Evidence for Chemical Transmission 
i 
I Over the past twenty five years there has been an accumulation of 
l'much data which provides evidence for chemical transmission in the peri-ipheral nervous system (Dale, 1938; Katz anq Miledi, 1962; Hebb and 
Smallmon, 1957; Whittaker and Sheridan, 1965; Wilson and Ginsburg, 1955; 
Krupa, 1963; Von Euler, 1966; Curtis, 1964). However, data pertaining to 
the role of chemicals as transmitters in the central nervous system (CNS) 
has been more difficult to accrue due to the anatomical and physiological 
complexities of these parts (Eccles, 1964). 
Generally, satisfaction of the following criteria is considered 
proof of transmitter function: 
1) nte proposed substance must be identified as being present in 
neural tissue in question; 2) nte substanc~ must be released and 
must produce a physiological effect upon stimulation; 3) An enzymatic 
system of synthesis and degradation must be present to produce a constant 
supply of the substance; 4) ntere should be storage mechanisms present 
in the area in question; 5) Neurons receptive to the substance must be 
demonstrated - and finally; 6) Pharmacological analysis should demonstrate 
t 
la similarity between exogenously applied and endogenously released trans-
t 
lmitter substance. 
b When the data relevant to the transmitter role of a compound such as repinephrine in the central nervous system is compared with that of ,......,,.,..,._.,,.-.,,)-·---------------------- ; j I l I ·---ii 
jacetylcholine at the peripheral synapses, the proof of the transmitter 
I' )role of norepinephrine centrally is not conclusive. 
! 
! This evidence suggesting a central transmitter role for norepine-
f 
'phrine includes the following observations: 1) There are regional brain 
!differences in the distribution of norepinephrine which appear to be 
related to certain neurophysiological sub-systems of the nervous system 
f (Rech et al., 1966; Van Rossum, 196 7). 2) ·High levels of the enzymes 
related to the synthesis of norephinephrine are associated with structures 
that look like synaptice vesciles (Michaelson et al., 1963; De Robertis, 
11966). 3) By fluorescent techniques catecholamines have been localized 
to the CNS {Dahlstrom and Fuxe, 1964; Fuxe, 1965; Falck et al., 1962). 
4) Fluorometric analysis of whole brain amines {Shore and Olin, 1960; 
Weigen and Pery, 1961; Everett, 1961) have also documented the presence 
of catecholamines centrally. 5) Induced neural activity changes brain 
norepinephrine levels (Reis and Gunne, 1965). 6} Microiontophoresis and 
intraventricular administration of the amines and substances relating to 
their synthesis and degradation have electrophysiological and behavioral 
effects. 
There are many technical problems involved with any attempt to use 
the peripheral nervous system as a model for studying a possible trans-
mitter in the central nervous sy~tem. The dendrites are numerous and 
small, and packed within a tangle of glia. This makes isolation and 
chemical and physical manipulation very difficult. There are, of course, 
neural tracts and specific areas of known physiological activity (Fuxe 
et al., 1965). However, the separation and identification of separate 
' I 
I 
I 
I 
t.---------~-•-•w•·-... ---------------------------·;i1rc . .J 
2 
neuron cell bodies is extremely difficult. 
It is difficult but possible to obtain by activation of neural tracts 
and areas in the central nervous system discrete, replicable, physiolog-
ical phenomena such as the miniature end-plate potential obtained by 
fsuitable electrode placement in the peripheral nervous system (Eccles, 
!1964). 
' l 
i Catecholamines as Modulators 
i ! The administration of drugs which have been found to affect levels 
lof the amines in the central nervous system and which also affect be-
fhavior has led to numerous speculations based on a supposed transmitter 
Jand/or modulator role of the catecholamines and serotonin (Everett, 1961; 
• j Everett and Weigard, 1962). These speculations often are present as 
'hypothesis relating behavioral states to the adrenergic, cholinergic, 
' 1 i dopaminergic, serotonergic, etc., "systems of the brain". An investi-
1 gatiort into the role of adrenergic and serotonergic systems in behavior 
iis the basis of the research presented in this thesis. I Catecholamine Metabolism 
[ Catecholamines are low-molecular-weight substances which contain a 
j 
jcatechol nucleus and an amine group. The more cOIIElonly studied catecholes 
l•re dihydroxyphenylalanine (dopa) and its metabolic products, dopamine, 
lnorepinephrine and epinephrine. These compounds are synthesized from 
1 their precursor, tyrosine by a known series of enzymatic reactions. The 
! 
:amino acid tyrosine, normally present in the circulation, is concentrated 
I l in neural tissue by an active transport mechanism. Tntraneuronally 
I 
f tyrosine undergoes three specific enzymatic transformations which result ! 
I i ,,.,,,....,....,1"-IW-•-------.-~...,.y,.,;,,..,.....,._.,.,.-•~ _,,.~._...._...._~_, _______ U ___ ,___ !11 .. ---·lt .. -,,., ...,.....,,......_......,.,, , ...,. .. _,,, .. ,,.,.,,.J. 
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·in the production of norepinephrine. In those cells which contain the 
.enzyme needed to snythesize epinephrine, there is an additional intra-
!cellular migration of norepinephrine, from the granule to the cytoplasm 
I 
ifor N-methylation, and then back again to the chromaffin granule for 
f 
l 
, storage. 
I 
The following is a diagram which illustrates the biosynthesis 
!of catecholamines 
I 
in brain, chromaffin cells (adrenal medulla) and 
lsympathetic nerve endings (Fig. 1). 
f 
' 
Serotonin Metabolism 
Serotonin (5HT) is an indol amine which is synthesized in the brain I I from the amino acid tryptophan. The following is a diagram which ill-
' lustrates the biosynthesis of serotonin (5HT) (Fig. 2). j 
I The catecholamines are degraded by the enzymes monoamine oxidase 
;and catechol-o-methyl transferase. Serotonin is also degraded by the I . 
lenzyme monoamine oxidase. Drugs which affect each of these enzymes will 
f be considered in the following chapter as they affect the brain levels of 
ithe amines and serotonin (Chapter II, d). 
! 
J Catecholamines, Serotonin and Behavior 
I The causal effects of brain catecholamine levels and serotonin 
'levels on behavior have not been clearly substantiated. The following 
1statements are examples from published papers. "A case can be made for 
·f 
f the catecholamines having either central excitant or central depressant 
I actions" (Marley, 1966). "With the facts so far available it is not 
'possible to say what function dopamine has in the central nervous system", 
! I (Bertles and Rosengren, 1966). An still in reference to psychiatric states 
i in humans, the evidence as a whole does not permit assigning importance to 
i 
l. .. "-~---·;;~."-.... ~~-.~,_,_. ___ ,, ,_,,-. ..,."·~<!..·~,--··-I ,..,...,.·--·~,..-.,.--------~ - . __,.J;ilflj~......_,.,.,.-,..,-,.,,.,.,.' .. ..,,..,, . ..,...' 
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I 
l 
l 
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i 
! the catecholamines specifically" (Kety, 1966). 
I 
Dr. Dews in a symposium on catecholamines stated that studies of the 
~ 
!effects of Biogenic Amines on Operant Behavior show that the complex be-
'havioral output of an intact animal can be effectively used to study drug 
I 
f interactions and antagonisms. He concluded, hc;wever, that "studies of 
l 
ltransmitters and related compounds have shown that patterns of behavior as 
la whole tend to be suppressed or enhanced, without specific reference to 
~individual components of the behavior" (Dews, 1968). I This attitude ·is not shared by all iuvestigators, however. Frequently 
ja direct relationship is implied when a behavioral state is found along 
I.with altered amine levels as the result of drug administration. A direct 
I 
correlation for example between psychosis and serotonin is presumed by 
Some drugs which significantly alter the brain levels of biogenic 
!amines in animals also produce changes in behavior. A classical example 
!. 
l 
f of this is reserpine which produces many behavioral effects, such as 
t 
jsedation, a loss of conditioned avoidance, a decrease in self stimulation, 
f and a behavioral state in rats analogous to clinical endogenous depression 
f jinman (Kety, 1967a). 
I 
A remarkable correlation persists between the action 
' jor reserpine and its effect on catecholamines suggesting that the action 
lof reserpine on behavior is dependent on its effects on the central amines 
f (Kety, 1962). 
f Because drugs such as reserpine and monoamine oxidase inhibitors affect 
L ..._.. .. , "-·-.... ,.,..-.~-.~ ---~ .. ··-··---------------------·-··· .,. .. ,.~~ ... .,.J 
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;more than one amine similarly, they have not been useful in relating 
;£.articular amines to their behavioral effects. Other drugs such as 
' 
' 
'specific precursors, and specific inhibitors have been of greater value. 
i 
! 
1Th.ere will be discussed in detail with regard to their phannacological ; 
' 
!activity and effects on behavior in the following chapters. 
l 
I ! -"-Methyl-p-tyrosine, which blocks tyrosine hydroxylase and lowers 
!brain catecholamine levels but not at all 5HT levels, has been reported 
Ito produce sedation in man (Sjoerdsma et al., 1965). 
l 
I P-Chlorophenylalanine, which blocks the synthesis of SHT in the 
! 
' f )brain without affecting other amines such as norepinephrine or dopamine, 
l 
i 
Jhas been examined for its effects on behavior. It does not appear to 
!produce sedation even though SHT is reduced to minimal levels in the brain 
i I (Koe and Weissman, 1966). 
Most drugs which rather specifically alter affective states in man 
iand behavior in animals have been shown to interact in some manner with 
f 
tbiogenic amines in the brain. 
Reserpine which was used in psychiatry in the treatment of mania and 
l 
lexcitement prior to the introduction of the phenothiazines and is used 
I 
iin general medicine in the treatment of hypertension has been reported to 
i 
i )produce severe depression of mood in some patients, particularly hyper-
f tensive patients treated with relatively large doses (Glowinski et al., I ~ 
il965). Depression has also been observed in patients given tetrabenazine, 
: 
}a drug which is similar to reserpine in its effects on biogenic amine 
~metabolism (Lingjaerde, 1963). 
The effects of reserpine have been extensively studied in experi-
8 
< imental animals and in-vitro systems. By a mechanism which has not yet 
i. 
been completely elucidated, reserpine interfers with the intraneuronal 
ibinding of the catecholamines and serotonin (Carlsson et al., 1957). With 
i 
~the binding thus impaired the amines may diffuse freely through the cyto-
~ 
jplasm and attach to mitrochondrial monoamine oxidase. This results in 
! 
itheir inactivation by deamination and thus, in depletion of tissue amine 
I 
)stores. Reserpine-induced sedation in ani~ls is associated with decreased 
I 
lbrain levels of norepinephrine, dopamine and serotonin (Carlsson et al., 
1963). 
There have been reports of a temporal association between the return 
I h d h 9of normal motor behavior in animals sedated wit reserpine an t e restor-
ation of the brain's capacity to acctnnUlate both norepinephrine injected 
!into the cerebral ventricles and serotonin synthesized from the exogenously 
I 
iadministered precursor 5-hydroxytryptophan (Brodie et al., 1966). These 
I 
;findings support the hypothesis that reserpine induced sedation is related 
I . 
' lto imp~irment of the binding of monoamines, but the data do not allow 
f separation of the effects of catecholamine depletion from those of sero-
1
. tonin release or depletion. However, relevant data come from studies in 
which the amino acid precursors of catecholamines and serotonin have been 
!administered to animals previously given reserpine. These precursor amino 
Jacids, unlike the monoamines, can cross the blood-brain barrier in animals 
-~ . 
i 
!and raise the concentrations of the respective monoamines in the brain 
I (Carlsson et al., 1957). Administration of dihydroxyphenylalanine, the 
I 
I catecholamine precursor, reverses reserpine-induced sedation in animals 
{ 
f and restores gross behavior to approximately normal levels (Carlsson et al., 
:.;.,.,_ ........... , .-.... -~ .. --....-.-~.~-~ ... ~···"""l-----------------------· ---· -·---- .... ~ .. 
9 
I 
i 
I 
' 
' 
·I 
I 
• ! 
.--l 
,1963; Everett and Toman, 1959). The serotonin precursor, 5-hydroxytrypto-
' 
!phane, however, does not restore normal functioning (McGeer et al., 1963). 
' )These findings suggest the importance of catecholamine depletion in re-
• . 
I 
~serpine-induced sedation in animals, and possibly depression in man. 
I 
I 
Based on the studies of Everett, Carlsson and others dopamine is now 
(merging as an important neurotransmitter in its own right. Previously 
!dopamine was thought of primarily as a precursor to norepinephrine with 
I 
ilittle action of its own. Dopamine in some cases is better correlated 
' lwith changes in behavior than norepinephrine (Creveling et al., 196.8). 
' jAlong this same line interest in dopamine as a neurotransmitter has been 
!fostered by H~rnykiewicz (1966) who showed a deficit of dopamine in basal 
ganglia of parkinson patients. 
L-Dopa, the precursor to dopamine, is now widely used in the treatment 
of parkinsons disease (Boullin and O'Brian, 1970). When theorizing about 
the possible function of neurotransmitters one nrust not talk of catechol-
1 amines in general but must distinguish between.the two amines, norepine-
phrine and dopamine. 
A neurochemical theory, the catecholamine theory of mood, states 
acts on norepinephrine levels only. They include cocaine, amphetamines, 
monoamine oxidase inhibitors, lithium, phenothiazines, and metabolic 
~ inhibitors. '-~··"_-'_«_, _____ '""~"'·'-·--mo •• -R·---· ----------
10 
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. 
However, as far back as 1914, research has verified that epinephrine 
1or norepinephrine, when given so that it passes the blood-brain barrier 
! (that is, intraventricularly or intravenously into animals with inmature 
! 
iblood-brain barriers), produces a dose-response pattern of behavioral 
\ . (depression, lethargy, sleep, sedation, and stupor (Boss, 1914; Morinesca 
'et al., 1929; Leimdorfer and Metzner, 1949; Sherwood and Richter, 1955; 
Rothballer, 1959; Milhand and Glowinski, 1963; Brittain, 1966). 'l'hese 
and other contradictory reports in both man and animals have lead to these 
; conclusions: "At the present time, the neurophannacological psychochemical 
research approach rests on insecure bases both in terms of the establish-
ment of what are necessary and sufficient conditions in brain chemistry 
to explain the metabolic effects of the drugs and in terms of the connection 
of these changes with predictable behavioral phenomena" (Mandell and 
Spooner, 1968) • 
'l'he effects of amine levels generally are apparent only when the 
! ~ levels are greatly changed. Norepinephrine must be almost depleted before 
I the behavio}l'al effects of depletion are seen. "The actual content of 
Ji' amines of I the tissues is of only minor importance for the function" 
I (Carlsson et al., 1963). 
I j Behavioral states induced by drugs such as _L-dopa, phenethylamine, 
I 5-hydroxy-tryptophane, and tryptamine have been all lumped as one "psy-
i ~ 
I chosis" although obviously different to a careful observer (Randrup- and Munkvad, 1966). Surely, if a direct correlation exists between levels of 
i 
Jbrain amines and behavior, the behavioral symptoms resulting from general 
I . 
11 
f accumulation of depletion of amines by different drugs should be similar. 
t .... """" .,. ______ ,_. .............. , .... ..........,._. .... _.,.,~,¥'"~--------.u.-·----------·--------,··------' 
. This has generally not been the case, hOW"ever, based on the work done in 
;this area. 
In studies in which drugs are not employed, correlations have been 
:found between amine and serotonin levels and emotion (Pryor et al., 1964), 
;stereotypy and shock latencies (Scudder et al., 1968), and audiogenic 
} 
!seizures (Schlesinger et al., 1965). 
I Soote affective states in animals are accompanied by great alterations 
lin the central catecholamines. Welch and Welch (1965) found a lower brain 
jnorepinephrine content in mice which were isolated than animals kept in 
f aggregated groups of 25. Maynert and Levi (1968) found a 40% reduction 
1. 
> jin brain norepinephrine concentration in rats following electrical shock 
r 
1 to the feet. Barchas and Freedman (1963) found a fall in Brain NE levels 
f 
' 
'and an equivalent rise in brain 5HT levels follOW"ing a swimming stress 
I {in rats. Liberson (1964) reported a significant change in brain 5HT 
l 
1content as a result of behavioral stress such as.fixation. If external 
I 
;sensory inputs such as those arising from stre~s, shock, isolation and 
1 
I training modifies amine levels, it might be expected that any drug which 
f ' 
linduces internal change sensed by afferent nerves which record an animal's 
' 
:'.internal environmen.t might produce a change in· amine and serotonin levels 
i 
Jby the same mechanism. The amine levels may not be a cause of behavior 
I !,but a result of a sensory stimulus. 
! 
I 
The strength of drug effects on animal behavior varies depending on 
I, the excitability of the central nervous system regardless of whether or 
: not amines are affected by the drugs (Souskovi, 1964). Furthermore, drugs I j 
·.:affect specific behaviors in ways quite apart from simple changes in rates 
12 
.i 
I 
' ! 
I 
I 
! 
l 
I 
of task performances or amine level changes; in.other words, drug effects 
are related to specific temporal sequences or responses and stinruli which 
constitute behavior and over which amine levels may change in a non-
specific way (Kelleher et al., 1964). 
As a result of recent advances in Radioactive tracer methodology the 
rate of synthesis or so called "turnover rate" of catecholamines and sero-
tonin has been determined (Costa and Neff, ·1969; Neff et al., 1969). There 
are various methods used to determine the "turnover rate" of catecholamines 
and serotonin. These include .!!! Vivo Studies and In Vitro Studies. The 
use of radioactive labeled precursors, 14c tyrosine and 14c tryptophane, 
in in vitro and in ~ studies is based on the fact that 14c has a long 
half life; 5720 years and that 14c will remain attached to the tyrosine 
or tryptophane molecules as metabolism of the amino acids proceeds to the 
products norepinephrine and serotonin respectively (Wang and Willis, 1966). 
Thus a radioactive product is fonned which can be identified by means of 
liquid scintillation (Costa and Neff, 1969). ~ 2c is the normal carbon 
atom attached to the monoamin~s. The 14c can be attached biochemically 
at various .carbon positions, e.g., C 1, 2, or can be uniformly attached 
to the amino acid. The attachment of the 14c does not interfer in any 
way with the metabolism of tyrosine or tyrptophane nor does it interfer 
with its function. Although radioactive labelled precursors are expensive 
' 
they are readily obtainable and relatively safe to use. 
The determination of "turnover rates" of catecholamines and sero-
tonin has added some information as to the function of these biogenic 
13 
.., 
I 
I 
I 
____________ J 
14 
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I j 
! 
Recent studies have shown signifi-
housed animals; this finding suggested a decrease in brain serotonin 
synthesis and inactivation for mice isolated over a prolonged period of 
time. It was suggested that the changes in brain serotonin metabolism may 
in. this instance account for the behavioral differences found between 
isolated and group-housed mice. 
j 
~ 
I. Tricyclic antidepressants are effective in the treatment of some depressions, and it has been suggested that the clinical effects of these 
I 
drugs may be related to their effects on biogenic amines in the central 
nervous· system. Schildkraut et al. (1971) found the turnover of norepine-
phrine was decreased after acute administration of tricyclic antidepressants 
but increased during chronic administration of these drugs. This increase 
in norepinephrine turnover occurred sooner when thyroxine was administered 
with the antidepressant. The suggestion was made that this may help to 
explain why clinical antidepressant effects are generally observed only 
after chronic administration of imipramine or protriptyline and why thyroid 
hormone may accelerate and enhance the clinical antidepressant effects 
15 
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l of imipramine. I It seems true that metabolic paths relating to the amines are very 
i labile because almost any stress in the environment or internal millieu 
' t I causes fluctuations in the amines. The purpose behind these experiments 
Ii• to study the amines and behavior in an attempt to find a correlation 
between the two, and to discuss a possible mechanism of action responsible 
for the changes in behavior. The research·was not intended to prove or 
support a tight causal transmitter actuated behavioral mechanism, but it 
can be seen from the above brief survey that there is a need for studies 
on the relationships between amine and serotonin levels and behavior. 
This research is extremely important both to clear the air of needless 
suppositions and hypothesis and to provide a comprehensive ground plan to 
guide further research. In defense of the resulting conclusions the author 
than determinents of be-I would like to quote the following: .tIUst talk about emperica1 correlates rather "Even on a neurochemical level, we 
haviora.l states. Rigorous establishment of the transmitter or modulator 
role of brain substances appears to remain for the future" (Mandel and 
Spooner, 1968). 
r Chapter II 
MATERIALS and METHODS 
Animals 
All the animals used in these studies were male, 60 ± 10 day old, 
ICR mice 'purchased from Scientific Small Animal Laboratory. Prior to the 
experiments the animals were housed for at least three weeks, fifteen to 
a cage, in an environmental chamber at 75 degrees ± 5 degrees F with an 
8 hour light cycle. The animals were fed on Purina mouse pellets apd water 
available ad lib idum. 
Behavioral Test 
The enviromnental situation was a "Mouse City" set-up made of plexi-
glass. It is composed of six small home cages (5" x 7" x 4") each 
connecting·with a central communal chamber (18" x ll" x 6") by means of a 
. funnel-like, 12" x l~" cylindrical runway made of plastic tubing (Fig. 4). 
Illumination was provided for all chambers by a diffuse overhead 40 watt 
red light. Sawdust was placed on the floor .of all the chambers, and food 
pellets and water were provided in the central chamber. 
In the city experiment, two aggregated males, which were naive to one 
another, were weighed; the animals were marked with dye for the purposes 
of identification, and after suitable drug pre-treatment one pair was 
( 
placed in each of the small "home" cages of the "city". The experiment 
proper was initiated fifteen minutes later, at which time cotton plugs 
separating the "home" cages from the cOlllllUnal chamber were removed so that 
the animals were free to interact. At five minute intervals the behavior 
16 
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Floor Plan of "Mouse City" 
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Fig. 4 
Diagram of Mouse City 
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the initial fifteen minute pre-experiment period). Thus, fifteen five-
minute checks per experiment per mouse wer~ made, each corresponding to 
a distinct behavioral trait. Altogether, twenty "city" experiments, each 
using naive mice, were conducted per drug group. Twenty saline control 
cities were also conducted. The mouse "city" experiments were run in the 
afternoons between one and four o'clock. 
The behaviors measured in the "city" were defined as follows: Motor 
movement from any one chamber to another, devoid of aggression and distinct 
from·rapid flight, was recorded as exploration. Any other motor activity 
concerned, for instance, with fighting or gathering food, was not recorded 
as explf?ration. Digging consisted of clawing at, piling up or re-arranging 
the sawdust. Carrying things was defined as transportation of food pellets, 
feces, sawdust, etc., from one point to another, whether or not it was 
subsequently eaten. Attack (aggression) was defined as a movement toward 
another animal accompanied by a bite. An animal was listed as attacked . 
if it was bitten: An attack was~recorded as ended when the attacker re-
leased the attacked. (The separation before renewal of an attack was 
often brief.) Sexual behavior was defined as mounting, accompanied by 
~n ef ~ect of the enviromnent (e.g. repeated small jumps in one spot, 
I 
sommersaulting, running in circles, etc.). In the act of freezing mice 
became motionless and rigid; slight tremors were usually noticed and often 
they "froze" in a semi-erect position, i.e., on their hind legs. '11tis 
behavioral trait could be readily differentiated from resting or sleeping; 
it was generally, but not always, a response to a disturbance. Sleeping 
animals were usually found in a curled up position, their eyes were closed 
and their breathing was slow, deep and regular. Ingestion was defined as 
any intake of food or water. Self grooming and grooming other mice con-
sisted of the animal contacting gently with its mouth, tongue, teeth or 
paws either its own body or that of another animal, respectively. '11te 
term being groomed is self explanatory. Any unique or unusual trait 
(e.g. catatonia) was also recorded at the five-minute check period. 
Biochemical Determination ** I The measurement of the biogenic amines was by means of an Aminco 
!Bowman Spectrophotoflurometer according to the technique of Wiegand and 
Perry (1961). Four pooled whole mouse brains were homogenized in two 
volumes of 0.01 NHCL and extracted using four ml of homogenate, two gm 
of NaCL and twenty-five ml n-heptane into four ml of 0.01 N HCL. In each 
extraction the tubes were.shaken at 250 counts/minutes for ten minutes. 
Aliquots of 0.6 ml of this final acid extract were analyzed for norepine-
19 
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I 
I 
phrine and epinephrine using pH 5 and pH 3 buffer respectively. Fluorescence 
I 
t .. A special thanks to Dr. Guy Everett from Abbott Laboratory for the use of-,his lab, technician, and equipment while I was learning the 
fundamentals of the biochemical techni ue. 
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was measured in the spectrophotofluorometer at a wavelength of 397 mu 
and 508 mu. 
Of the acid extract 1.0 ml was placed on a water-washed Dowex 
50 x 4 (200 - 400) mesh, Na-form colunm, 2 nm high and 5 mm wide. The 
sample was washed with a single application of 2 ml of water. The dopa 
was eluted in one tube with 8 ml of 0.025 M sodi\Dll phosphate buffer pH 
6.5, and the dopamine was eluted in a second tube with 8 ml of the same 
buffer containing 1 M<Cl. Because fluorescent intensity developed slowly 
in these samples unless they were irradiated fluorescence was determined 
22 hours later at activation and fluorescent wavelengths of 334 nu and 
380 mu respectively. 
The remainder of the acid extract was used for the analysis of 
serotonin by measuring fluorescence of the extract directly at the wave-
lengths.of 300 mu and 342 mu. An acid blank and standard solutions of 
dopa, dopamine, norepinephrine, epinephrine and serotonin were subjected 
to the same manipulations as the samples. 
· lbus, during one determination the brain levels of dopa, dopamine, 
norepinephrine, epinephrine and serotonin were analyzed. The concentrations 
of the biogenic amines and serotonin are given as..ug/gm wet weight in 
Table II, and as percent change from control in subsequent experiments. 
Recovery experiments were conducted prior to the present set of 
( 
experiments; 90% of the norepinephrine, 71% of the dopa and 75% of the 
dopamine standard added to control aliquots were recovered. Approximately 
75% of the serotonin was recovered. Since these readings were constant 
over a series of experiments and since the concentrations in brain are 
21 
given as percent change from control brain values, recovery experiments 
were not conducted with each determination. However, a saline control 
l 
I 
I 
was conducted with each set of experiments, and the values for the amines 
were almost identical in this case. 
The mice used for the biochemical determinations were taken from the 
"mouse city" at the mid point of a regular "city" experiment (i.e., 35 
minutes after the initiation of the experiment). Behavioral determinations 
were not recorded for these experiments. The levels of amines of the 
sacrificed mice were presumed parallel to those of the mice which were 
kept for a complete "city" run and whose behavior was quantitated. The 
animals used for the biochemical determinations were taken from the 
environmental (city) situation to eliminate any variable due to possible 
effect~ of this enviromnent on biogenic amines and serotonin (cf. intro-
duction). Although the behavior of the sacrificed mice piror to their 
deaths was not recorded, it was judged similar in all ways to the corres-
ponding.control or drugged "city" mice. 
Drugs 
All drugs were made up in saline and administered i.p., in a 0.01 
ml/gm of mouse weight volume. 
Two mg/cc of tragecanth were added to suspend (CPlO) parachloro-
phenylalanine and "-MPT) alpha-methyl-paratyrosine in saline. Certain 
abbreviations are used in this paper as follows: 
CNS = central nervous system 
NE = norepinephrine 
E = epinephrine 
~MPT =methyl-para-tyrosine 
CplO = parachlorophenylalanine 
MADI = mono-amine oxidase inhibitor 
5HTP = 5-hydroxy tryptophane 
5HT = (serotonin) 5-hydroxy trypt amine 
L-DOPA = dihydroxyphenylalanine 
IlA = dopamine 
Mechanism of Action of Drugs Used 
(Fig. 3) 
J..-methyl-para-tyrosirie ( MPr) 
~MPT inhibits the enzymatic formation of Dopa from tyrosine. Speci-
of tyrosine hydroxylase and as such re-
(Moore, 196 7). Since ~MPr does not 
affect brain 5HT ievels, this agent is a valuable tool for investigating 
the significance of catecholamines in the central nervous system 
(Spector et al., 1965). 
This drug has been extensively used as a pharmacological tool for the 
investigation of brain catecholamines (Moore, 1%8; Rech et al., 1966; 
Levitt et al., 1965). 
I Pargyline (M0-911) . The enzyme monoamine oxidase is responsible for the degradation of the 
' 
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DRUG 
Pargyli ne (M0-911) 
L- Dopa 
5-Hydroxyt ryptop ha n e 
( 5- HT P) 
o-methyl-p-tyrosine 
(Ol-MPT) 
I P-chlorophenylalanine ( CP-10) 
I 
I 
DOS AGE 
100 mg/kg 
50mg/kg 
IOOmg/Kq 
80 mg/kg 
· 3!6m9/kg 
Fig. 3 
Mech of Act 
MAO In hi b 1 t or 
NE Precursor 
5HT Precursor 
Tyrosine Hydroxy lase 
Inhibitor 
5HT Synthesis 
Inhibitor 
Drugs, Dosage and Mechanism of Action 
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I catecholamines and serotonin. This enzyme, along with catechol a-methyl 
l 
f transferase (COMT) plays a key role in controlling the amounts of NE, 
f 5HT and DA stored in the brain (Spector et al., 1960). Pargyline inhibits 
f 
the enzyme monoamine oxidase so that its administration leads to a marked 
increase of endogenous amines and serotonin (Shore and Olen, 1958; 
Spector et al., 1960; Quastel, 1965; Wiegand and Perry, 1961). 
(P-chlorophenylalanine) (CP-10) 
P-chlorophenylalanine blocks the synthesis of SHT in the brain with-
out affecting other amines such as norepinephrine or dopamine (Koe and 
Weissman, 1966). 
P-chlorophenylalanine inhibits liver tryptophane hydroxylase in vitro 
and strongly suppresses the tryptophan and phenylalanine hydroxylating 
capacities of liver treated with it (Koe and Weissman, 1966). These 
results suggest that P-chlorophenylalanine may effect 5HT depletion by 
f 
inhibiting the biosynthesis of this monoamine probably by blocking tyrpto-
lphan hy~roxylation. It has also been suggesteq that CplO may interfere with 
uptake of the precursor 5HTP (Pletscher et al., 1963; Pletcher et al., 1964). 
(5-hydroxytryptophane) - SHTP 
SHTP is the immediate precursor of 5HT in the biosynthetic pathway 
of this monoamine. Injection of SHTP will increase the amounts of 5HT 
!in brain tissue (Undenfriend et a;., 1956). 
L-Dopa 
Dopa is the precursor to dopamine, norepinephrine and epinephrine in 
the biosynthetic pathways of these biogenic amines. Injection of L-Dopa I will increase the levels of these substances in brain tissue (Wiegand and 
24 
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!perry, 1961; Guroff et al., 1961; Yoshida et al., 1963). Nonspecific de-
! 
jcarboxylation by which dopamine is formed from dopa occurs throughout the 
i 
ibrain and the regional distribution of the decarboxylases generally follows 
fthat of catecholamines (Bertles and Rosengren, 1959). 
i 
i L._ I I __________________________ ...._..,..,,...,,,..,_..._.;: 
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I ! Chapter III 
! EXPERIMENTAL DESIGN 
I I The purpose of this experiment was to administer drugs which would 
I 
selectively raise or lower the levels of the catecholamines and/or sero-
tonin while carefully noting the behavioral results. On the basis of 
the literature and previous pilot runs, dosages were used which were 
found not fatal to the mice. 11le control "city" study (Exp. I) represents 
an average of 20 "city" experiments. 11lere was no appreciable difference 
between consecutive similar runs. An occasional hyperactive, aggressive, 
or sleepy mouse did not appreciably change the average number of counts 
per "city" experiment from one experiment to another in the controls or 
drug experiments. 11le behavior of the animals is given for each experi-
ment as a numerical index (average number of checks per experiment per 
mouse). Table I lists experimental numbers, the drugs used and the 
number of "mouse city'; runs and animals used in· each experiment. 
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TABLE I 
EXPERil1ENT NO. DRUG NO. OF "MOUSE CITIES" NO. OF ANIMALS 
PER II c ITY" 
x 
XI 
XII 
XIII 
XIV 
xv 
~A.-Methyl-p-tyrosine 
80 mg/kg 
5-hydroxy-tryptophane 
100 mg/kg 
Pargyline 100 mg/kg 
~-Methyl-p-tyrosine 
80 mg/kg 
L-Dopa 50 mg/kg 
«--Methyl-p-tyrosine 
80 mg/kg 
L-Dopa 50 mg/kg 
-Parachlorophenylalanine 
316 mg/kg 
-Parachlorophenylalanine 
316 mg/kg . 
ol---Methyl-p-tyrosine 
80 mg/kg 
-Parachlorophenylalanine 
316 mg/kg 
Pargyline 100 mg/kg 
5-hydroxytryptophane 
100 mg/kg 
ot..-Methyl-p-tyrosine 
80 mg/kg 
UBLE I 
20 12 
20 12 
20 12 
20 12 
20 12 
20 12 
28 
r 
Evaluation of Data 
The biogenic amine data was analyzed for significance using an un-) I 
lpaired student-t-test comparing each experiment with the control. The 
! 
!higher variance among animals receiving drugs is possibly due to added I ~ 
isources of error. The rate of absorption of the drug, and the rate of 
synthesis of catecholamines and serotonin may vary from animal to animal, 
but the results were sufficiently consistent to permit a significant 
.. statistic. 
The data from "mouse city" are presented as the average behavioral 
experimental situation. Occasionally a homosexual mouse may give the 
.average se~al behavior a high number, but the standard deviation is also 
\ 
jhigh. 
I 
Those behaviors however which are shown by all animals during every 
iexperiment, e.g. exploration, provide satisfactory data for statistical I . 
; I analysis. Generally with such data the standard deviation ranges to about 
110% of the control values (Scudder et,al., 1969). With the introduction 
lof drugs into the experiment, new behaviors occur sporadically, replacing 
f the usual behaviors. The new behaviors are obviously significant and these 
jas well as the orderly decreases ~nd increases seen in the frequencies of 
!the more usual behavioral acts are the main variables of such experiments, 
I I 
i 
the data are presented here with confidence that similar trends would occur 
on further replication of the experiments. 
The results of the biogenic amine analysis are given in Table II. 
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; 
;A total of 15 separate determinations were run per each experiment. 
!Not nruch importance can be attached to the epinephrine levels as the 
!measurement of this amine is at the limit of the technique. Enormous 
f differences were encountered between treatment groups as to the levels of 
!catecholamines and serotonin. These changes wer~ in agreement with the 
specific drug effects expected on the basis of information provided by 
the literature and presented in the above e~perimental design section. 
Thus a monoamine oxidase (MAO) inhibitor, (Pargyline) followed by a 
serotonin precursor, «5-hydroxytryptophane) (5HTP), gave a large seio-
tonin (5HT) increase. Similarly Pargyline (MAO!) followed by a NE pre-
cursor, L-Dopa, gave a large increase in dopamine and NE. A depleter of 
NE, <l.MPT), removed selectively almost all of the NE. A serotonin de-
pleter (CP-10) removed almost all serotonin selectively in some of the 
experiments. Biochemical results of drug combinations were difficult to 
predict as stated in the experimental design. It.was in these cases of 
less commonly studied drug combinations that amine levels and behavior 
are probably not causally related was substantiated. 
It is not easy to present a reader with the many correlations which 
such data allows. To lessen confusion and augment reading, each experi-
ment involving either a control situation or a specific drug treatment 
is discussed separately in the order below and a general discussion of 
the entire picture stressing correlative similarities or relationships 
will follow (Chapter V). 
I 
I 
I 
I 
I 
I 
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Chapter IV 
RESULTS 
Table II represents the levels of DA, NE and SHT found in whole 
' !mouse brain before and after drug treatment. The levels here are ex-
i 
Jpressed in..ug/gm wet± SE weight. Experiment I is the saline control 
' jgroup. 
' I 
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EXPERIMENT DA NE 5HT 
I .875 ± .018 .465 ± .021 .650 ± .060 
II 1.330 ± .168 .628 ± .010 .566 ± .016 
III 1. 986 ± .185 .604 ± .010 1.822 ± .165 
IV 4.573 ± .210 1.023 ± .019 2.762 ± .142 
v .910 ± .019 .452 ± .016 1.462 ± .100 
. VI 1.967 ± .103 .797 ± .021· 3.812 ± .169 
VII .010 ± .012 .010 ± .010 .699 ± .142 
VIII .657 ± .016 .317 ± .018 3.170 ± .201 
IX • 744 ± .050 .303 ± .012 3.650 ± .198 
x .014 ± .010 .050 ± .014 2.080 ± .019 
XI 1.050 ± .260 .744 ± .126 2.600 ± .169 
XII .700 ± .198 .349 ± .010 .663 ± .101 
XIII .832 ± .091 .469 ± .025 .260 ± .014 
XIV .009 ± .012 .028 ± .065 .260 ± .016 
xv .041 ± .086 ;009 ± .014 2.110 ± .162 
TABLE II 
r 
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Experiment I 
f the following behaviors: 
In an average saline control "city" experiment the animals showed 
I 
TRAIT NUMERICAL INDEX 
-- Average uumbet of checks per 
experiment per mouse ± Sd. 
Exploring 7.0 ± .8 
Digging 0.3 ± .3 
Stereotypic Behavior 0.1 ± .1 
Sleeping 2.0 ± .1 
Freezing 0.1 ± .2 
Cont actual Behavior 0.1 ± .1 
Ingestion 0.5 ± .3 
Sexual Behavior 0.0 
Grooming Se 1f 2.0 ± .2 
Being Groomed 0.2 ± .2 
Grooming Other 0.5 ± .3 
Aggression 1.5 ± .4 
t:hart 1 
I 
t 
L-.~~~--~----~·~---·----~------------------------------------------..... 
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l 
Experiment I 
I 
I I These data represents averages from 20 "city" experiments in which the 
;animals were injected with saline. Saline administration has, of course, 
a slight depressant action (Meier and Huff, 1962). 
If the pre-treatment (housing and nature of aggregation) of the mice I 
is carefully standardized the behavior of tbe animals in the "city" is 
quite constant. Occasionally a very aggressive, homosexual, or stero-
typic animal is encountered. 
All subsequent behavioral experiments of this study were compared 
with these mean control values. Generally, mice have high values for 
exploration and low values for other traits. 
C~rtain other abnormal behaviors e.g. writhing, paralysis, and 
catatonia appear in drugged mice and are not entered on this chart I (Chart 
i 
1). 
I 
i 
I ~ 
j _ _.._, ______________________ __ 
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Experiment II 
DOSAGES AND DRUGS 
j l · 
L-Dopa 50 mg/kg 
L-Dopa 15 minutes before experiment 
AMINE BIOGENIC AMINE LEVELS 
% CHANGE FROM CONTROL 
DA + 55 p<.01 
NE + 35 p<.01 
E + 5 not sig. 
5HT - 3 not sig. 
Chart 2 
r 
36 
Experiment II 
COMPARISON WITH CONTROL "CITY EXPERIMENTS 
; I TRAIT NUMERICAL INDEX 
CONTROL DRUGGED 
Exploration decreased 7.0 ± .8 0.5 ± .3 
I Digging decreased 0.3 : .3 o.o 
Stereotypic Behavior decreased 0.1 ± .1 o.o 
Sleeping increased 2.0 ± .1 2.5 ± .4 
Freezing decreased 0.1 ± .2 0.0 
Contactual Behavior increased 0.1 ± .1 0.4 ± .4 
·Ingestion decreased 0.5 ± .3 o.o 
Sexual Behavior stayed the same o.o 0.0 
f Grooming Self decreased 2:0 ± .2 1.0 ± .2 
Being G~oomed decreased '0.2 ± .2 0.0 
Grooming Other decreased 0.5 ± .3 o.o 
Aggression decreased 1.5 ± ;4 o.o 
Catatonia increased 0.0 10.0 ± .2 
Chart 2a 
I 
I 
1-·~,-------------------------------------
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! 
Experiment II 
For the first hour of the experiment the animals were in a catatonic 
state. They held their tails erect and rigid, resembling a "Straub" 
tail. The mice were seemingly not aware of each other or of their environ-
i 
lment. The animals upon being_placed in the "city" would asswne a rigid 
iposition and hold it no matter how awkward ·the position appeared~ After 
(the first hour the mice relaxed to a resting-sleeping position, never 
I going through the excited exploratory phase usually seen when an animal 
is placed in a novel environment. Nothing unusual was noticed in their 
physical appearance. Body temperature was normal {42 degrees C) for 
this strain. 
Since there has been a s'light 5HT decrease a large DA and NE increase 
lin these animals, the amine changes may, presumably, be correlated with 
i 
ithe catatonia and depression. Some authors have·considered a change in 
j 
jsleeping 
i possible 
l I effects 
time to relate to an increase SHT line (Jouriet, 1969). The 
causal effects of th~ amines and serotonin on the behavioral 
seen in this experiment will be discussed later (general dis-
cuss ion). 
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Pargyline 
Pargyline 
DA. 
N 
E 
5HT 
100 mg/kg 
+ 127 
+ 30 
- 3 
+ 222 
Experiment III 
DOSAGES AND DRUGS 
24 hours before experiment 
Biogenic Amine levels 
% change from controls 
P.<.Ol 
p .<. 01 
not sig. 
P.2.01 
~Chart 3 
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Experiment III 
i COMPARISON WITII CONTROL "CITY" EXPERiliENTS 
I 
I TRAIT 1-
, 
~ 
i 
~ iExploration stayed the same 
f Digging stayed the same 
f stereotYJ?ic Behavior stayed the same 
·~ 
'Sleeping decreased 
iFreezing stayed the same 
jcontactual Behavior stayed the same 
r Ingest~on st.ayed the s~e 
jsexual Behavior stayed the same 
~ Grooming Se 1f decreased · I --
t Being ~o_omed stayed the same 
!Grooming Other decreased (Aggression decreased 
I 
t 
f 
Chart 3a 
NUMERICAL INDEX 
CONTROL DRUGGED 
7.0 ± .8 6.5 ± .5 
0.3 ± .3 0.2 ± .2 
0.1 ± .1 o·.1 ± .1 
2.0 ± .1 1.5 ± .2 
0.1 ± .2 0.1 ± .1 
0.1 ± .1 0.1 ± .2 
0.5 ± .3 0.4 ± .3 
0.0 o.o 
2.0 ± .2 1.8 ± .5 
0.2 ± .2 0.2 ± .2 
0.5 ± .3 0.4 ± .1 
1.5 ± .4 1.0 ± .6 
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Experiment III 
There was no significant behavioral diffe:rence between this "city" 
and a normal control saline injected "city" run. 
The increases in NE, 5HT and DA were without effect behaviorally. 
f These changes in amines are in excess of those changes seen when L-dopa 
1 alone was administered (Exp. II) and catatonia was seen. No catatonia was 
' . 
!observed in these pargyline treated mice. Pargyline although a more 
;profoundly ami:ne modulating drug than dopa, did not affect behavior ·as 
'did L-dopa alone. It was expected that the animals might show an increase 
in activity and irritability described by Everett (1961), but they did 
not even though the total amine level was doubled as compared to control. 
It was also expected that the animals might show an increase in stero-
typic behavior described by Randrup and Munkvad (1966) for rats; however, 
f this was not the case. 
I 
I 
I 
f 
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Experiment IV 
DOSAGE AND DRUGS 
Pargyline 100 mg/kg, L-Dopa 50 mg/kg 
Pargyline, one day before experiment, L-Dopa, 
15 minutes before experiment. 
BIOGENIC AMINE LEVELS 
% CHANGE FR<»! C~OLS 
,, M + 425 p<.01 
NE + 120 p<.01 
E + 3 not sig. 
5BT + 325 p<.01 
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Experiment IV 
CCMPARISON WITH CONTROL °CITY'' EXPERIMENTS 
. 
. 
IBAll NUMERICAL INDEX 
CONTROL DRUGGED 
Exploration decreased 7.0 :I: .8 . 1.0 :I: .3 
Digging stayed the same 0.3 :I: .3 0.3 :I: .4 
Stereotxpic Behavior decreased 0.1 :I: .1 o~o 
Sleeping increased 2.0 :I: .1 4.0 :I: .4 
Freezing remained the same 0.1 :I: .2 0.1 :I: .1 
Contactual Behavior decreased 0.1 :I: .1 0.1 :I: .1 
Ingestion decreased 0.5 :I: .3 0.0 
.S.exual Behavior remained the same 0.0 o.o 
Grooming Self decreased 2.0 :I: .2 0.5 :I: .2 
Being Groomed decreased 0.5 :I: .2 o.o 
.Aggression decreased 1.5 :I: .4 o.o 
Catatonia increased o.o 9.0 :I: .3 
Chart 4a 
~ 
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Experiment IV 
For the first hour of the "city" experiment the mice were in a 
catatonic state similar to the mice described in Exp. II, after which 
they returned to a resting-sleeping position. 
This effect has been presumed to be due to increase in norepinephrine 
and dopamine and is a "classic" experiment .often reported in the. literature 
(Wiegand and Perry, 1961). There was an increase in 5HT and NE; greater 
than that seen .after either drug alone, and a large increase in DA: In 
the "city" environment without close packing of the mice and subsequent 
aggregate effects, the excitement and irritability seen by others after 
pargyline and L-dopa administration was absent. This suggests that the 
environment may interact with the animals drugged condition to produce 
differential behavioral effects. 
The main behavioral effect seen in this exp~riment was a catatonic-
like depression. This effect may be considered to be a direct effect of 
the drug, L-Dopa on the CNS. There seems to be no proof that the 
amines need be involved per _!! in this catatonia for catatonia was not 
found in subsequent experiments when dopa was not employed yet amine 
levels were similar. This relationship will be further discussed in a 
following chapter (Chapter V). 
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I EXperiment V I 
i 
DOSAGES AND DRUGS 
5HTP 100 mg/kg 
5HTP 100 mg/kg 15 minutes before experiment 
Biogenic Amine Levels 
DA +4 not sig. 
NE 3 not sig. 
E - 4 not sig. 
5HT + 125 P.<.01 
Chart 5 
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Experiment V 
C<MPARISON WITH CONTROL "CITY'' EXPERlMENTS 
TRIAT NUMERICAL INDEX 
CONTROL DRUGGED 
EXJ>loring stayed the same . 7.0 ± .8 6.0 ± .5 
Digging stayed the same 0.3 :l: .3 0.4 ± .3 
'.·:, StereotyPic stayed the same 0.1 ± .1 0.1 ± .1 
,._, 
{' 
~ Sleeping stayed the 2.0 ± .1 2.0 ± .2 same 
Freezing stayed the same 0.1 ± .2 0.1 ± .1 
Contactual stayed the same 0.1 ± .1 0.1 ± .1 
Ingestion stayed the same 0.5 ± .3 0.4 ± .1 
Sexual Behavior stayed the same 0.0 o.o 
Grooming Self stayed the same 2.0 :Z .2 1.6 ± .5 
Being Groomed stayed the same 0.2 ± .2 0.1 ± .1 
Grooming Others stayed the same 0.5 ± .3 0.4 ± .2 
Aggression stayed the same 1.5 ± .4 1.0 ± .6 
Chart Sa 
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Experiment V 
The behavior of the animals receiving SHTP was in no way different 
from the behavior of the saline treated control animals. Joyce and 
~ Mrosovsky (1964) found a significant decrease in food and an increase in 
• 1 
~ water intake, and a motor retardation in rats receiving SHTP. It was 
expected, therefore, that in the present experiment a change in ingestion 
might be seen. This was not the case, however. Nor was any motor im-
pairment seen in this experiment as reported often in the literature 
(Joyce and Hurtwitz, 1964). The changes in behavior found by Joyce and 
co-workers will be further discussed in the following section (Exp. VI 
and Chapter V) . 
r 47 
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Experiment VI 
Pargyline 100 mg/kg 5HTP 100 mg/kg 
Pargyline - 24 hours before experiment: 5HTP 15 minutes 
before experiment 
Biogenic Amine Levels 
% change from controls 
~" ' 
DA + 126 P.<.01 
NE + 50 P.<.01 
E 0 
5HTP + 425 P.<.01 
Chart 6 
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Experiment VI 
COMPARISON WITH CONTROL "CITY'' EXPERIMENTS 
I 
I 
' 
Exploration decreased 
Digging decreased 
Stereot;ypic Behavior decreased 
Sleeping decreased 
Freezing decreased 
Contactual Behavior decreased 
Ingestion decreased 
Sexual Behavior stayed the same 
Grooming Self decreased 
~ Groomed decreased 
Grooming Other decreased 
Aggression decreased 
Paralysis 
Chart 6a 
NUMERICAL INDEX 
CONTROL DRUGGED 
. 7.0 ± .8 2.0 ± .2 
0.3 :Ir .3 o.o 
0.1 ± .1 o.o 
2.0 ± .1 0.0 
0.1 ± .2 0.0 
0.1 ± .1 o.o 
0.5 ± .3 0.0 
o.o o.o 
2.0 :E: .2 0.0 
0.2 ± .2 0.0 
0.5 ± .3 o.o 
1.5 ± .4 o.o 
o.o 15.0 ± .1 
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I 
I Experiment VI 
I 
i 
I All animals seemed paralyzed in the hind limbs and this led to an 
almost complete behavioral deficit. '11leir forelimbs and hindlimbs were 
abducted in a "spread eagle" fashion. '11le animals were tranquil for most 
of the experiment. During the last fifteen minutes of the experiment the 
animals assumed a resting position. '11lree .(3) of the animals had slight 
respiratory problems characterized by hacking and irregular breathing. 
The animals seemed normal until the 5HTP injection. 
'11le abduction or characteristic posture assumed by 5HTP treated mice 
may be due to t~e large serotonin increase which is the notable effect of 
./ this drug treatment although admittedly DA and NE increased also. '11lis 
increase was less than that of previous experiments and cannot be held 
accountable. for the unusual neuromuscular deficit. "Spread eagle" abduction 
has been reported to occur in animals after 5HTP _with or without pargyline 
pretreatment (Everett, 1959). As described in _Exp. V, motor deficit was 
the basis for the effect of 5HTP on avoidance behavior in rats (Joyce and 
Hurtwitz, 1964). Joyce and Mrosovsky (1964) reported increased drinking 
associated with high central levels of 5HT in mice. We saw no such 
behavioral change, in fact injestion decreased in our experiments. 
Joyce suggested many factors, from osmoreceptor effects to emotionality 
~ 
changes, to account for the increased water consumption. Important is 
her reference to Toman (1963) that the direct action of the amino acid 
precursor, 5HTP, may be involved. As was pointed out before, however, no 
neuromuscular deficit or motor impairment was seen in our experiments after I ..._ _____________________________________________.
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jSHTP was administered alone (Exp. V). 
This paralysis seen in this experiment will be discussed in a further 
(Chapter V) . 
/ 
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I Experiment VII 
! 
i 
t DOSAGES AND DRUGS 
~ ,, 
L 
r 
"' ' ~ 
cJ. MPT 80 mg/kg 
J..MPT: TID q 4 hours for one day, and one hour before the 
experiment. 
- 99 P.<.01 
NE - 98 P.<.Ol 
E - 6 not sig. 
5HT + 3 not sig. 
Chart 7 
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Experiment VII 
COMPARISON WITH CONTROL "CITY'' EXPERIMENTS 
i TRAIT NUMERICAL INDEX 
I 
I 
Exploration decreased 
Digging decreased 
Stereotypic Behavior decreased 
Sleeping increased 
Freezing stayed the same 
Contactual Behavior increased 
Ingestion stayed the same 
I 
Sexual Behavior stayed the same 
Grooming Self decreased 
Being Groomed. stayed the same 
Grooming Other decrea.sed 
Aggression decreased 
~hart 7a 
CONTROL DRUGGED 
·7.0 ± .8 2.0 ± .6 
0.3 ± .3 0.2 ± .1 
0.1 ± .1 0.0 
2.0 ± .1 10.0 ± .4 
0.1 ± .2 0.1 ± .1 
0.1 ± .1 2.0 ± .4 
0.5 ± .3 0.4 ± .5 
0.0 o.o 
2.0 ±·.2 1.6 ± .5 
0.2-± .2 0.2 ± .3 
0.5 ± .3 0.3 ± .1 
1.5 ± .4 o.o 
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Experiment VII 
I All of the animals were depressed and most slept throughout the 
!experiment. Piloerection was noticed during the first fifteen (15) 
I !minutes of the experiment occurring in 50% of the animals. No trembling I was noticed, however. llhen placed in the "city" the animals were wet 
ventrally. Body temperature, however, was normal for this strain (42 
degrees C). A viscous substance appeared around the genitalia. 
These animals had suffered a considerable loss of NE and DA. They 
were depressed, sleeping was tnuch increased as was contactual behavior. 
We thought that perhaps the low NE and DA level was causally related to 
the behavioral depression. A direct relationship between low NE and sleep 
is the·only consistant one from the data presented so far. Spector et al. 
(1965), Moore (1967,_ 1968) and Hanson (1965) reported thatµ.n>T produces 
I overt sedation and depression of conditioned behavioral responses. Weissman and Koe (1965), however, suggested that the depressant effects of 
~MPT were secondary to the toxicity of the drug. Rech et al. (1966) 
using multiple i.p. injections of ~MPT found that the drug caused impaired 
avoidance responding, retarded performance and spontaneous locomotor 
activity without producing obvious toxic effects. The content of J..MPT in 
~ 
the brain and depletion of brain norepinephrine and dopamine both exhibited 
a time course similar to that of the behavioral depression. Moore (1968) 
found a depression in avoidance conditioning of guinea pigs following 
J.MPT administration and related the depression to the early CA depleting 
53 
l----------~-----------------------------------' 
54 
r··...-----~---------------- ..... -... i ---... -1'1>----------~1 
i 
• 
' I i effects .,,..MPT. 
I 
l The depression and sleep seen in this experiment will be discussed 
lin a following section with regard to the causal effects of NE and DA on 
the behavioral effects seen (Chapter V). 
I.__ 
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I Experiment VIII 
! Pargyline 100 mg/kg. 1J-.MPT 80 mg/kg. Pargyline 24 hours before experiment. 
TID q 4 hours for one day and one hour before experiment. ) . 
BiQgenic Amine Levels 
% change from controls 
M - 25 p .<.01 
NE - 32 P.<.01 
E 
- 2 not sig. 
5HT + 380 P.<.001 
Chart 8 
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Experiment VIII 
CCMPARISON WITH CONTROL "CITY'' EXPERD1ENTS 
Chart 8a 
I 
l 
~ 
r 
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~ 
Experiment VIII 
All animals appeared as normal control animals. Nothing unusual was 
! !noticed in their appearance. Body temperature was normal (42 degrees C) 
l 
f for this strain. I The Pargyline apparently counteracts the.1-MPT sleep producing effects 
!observed in Exp. VII. Concurrently it prevented to a certain extent a 
depletion of NE and DA.. Presumably the sedation~ contactual behavior, 
and secretions seen in the previous study are due either to a very low 
NE or DA levels or a blockade of the direct toxic action of ~MPT by 
pargaline. The increase in 5HT by pargeline was seen previously (Exp. III) 
and is without behavioral effect. 
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Experiment IX 
DOSAGES AND DRUGS 
Pargyline 100 mg/kg, J..MPT 80 mg/kg, 5HTP 100 mg/kg. 
rargyline 24 hours before experiment. MPT TIO q 4 
hours for one day and one hour before experiment .. 
SHPT 15 minutes before experiment. 
BIOGENIC AMINE LEVELS 
% CHANGE FRCM CONTROL 
DA - 15 P.<.01 
NE - 35 p .<. 01 
E 
- 2 not sig. 
5HT + 400 P.<.001 
Chart 9 
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i Experiment IX f I 
' 
COMPARISON WITH CONTROL "CITY'' EXPERIMENTS 
TRAITS NUMERICAL INDEX 
COOTROL DRUGGED 
Exploration decreased 1.0 ± .8 o.o 
Digging dee reased 0.3 ± .3 0.0 
Stereotypic Behavior decreased 0.1 ± .1 o.o 
Sleeping de creased 2.0 ± .1 0.0 
Freezing de creased 0.1 ± .2 0.0 
Contactual Behavior decreased 0.1 ± .1 o.o 
Ingesti~ d ecreased 0.5 ± .3 o.o 
Sexual Beha vior stayed the same ·o.o 0.0 
Grooming·se _!!: decreased 2.0 ± ·.2 o.o 
~Gro omed decreased 0.5 d: .2 o.o 
Grooming Ot her decreased 0.5 ± .3 0.0 
Aggression decreased 1.5 ± .4 0.0 
Paralysis i ncreased 0.0 15.0 ± .3 
Chart 9a 
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Experiment .!! 
All animals were extensively paralyzed. This resulted in a complete 
behavioral deficit. Both forelimbs and hindlimba were abducted in "apread 
-. ... 
eagle" fashion. All animals seemed irritable and excited. 
--.. ...................... _ ...................... There appeared 
quick, jerky movements of the head, accompanied by constant sniffing of the 
~· ground. Piloerection was noticed in two -(~) ani•la. The animals seemed 
~ to rotate on their hindlimbs. All animals had respiratory pYoblema l I 
~ 
characterized by hacking and irregular respiration. Body temperature 
• averaged 1 degree below normal. The paralysis seen in this experiment ?-
was much more severe than that seen in Exp. VI. 
The animals appeared normal before the injection of 5HTP, NE and DA 
' were decreased but 5HT was much increased. The behavioral effect may be 
preslimed due to the 5HT increase - yet this increase was less than the 5HT 
level reached by an injection of 5HTP and pargyline together: (Exp. VI}. 
No mnine of 5HT level is therefore a really s~nd explanation for this 
toxicity in that different drugs (discussed in Chapter V) produced similar 
levels of amines and 5HT without such a toxic or behavioral syndrome. 
Since the neuromuscular deficit was so great, a potentiation of direct 
5HTP toxicity seems the most logical explanation because the 5HT level 
causing this pronounced paralysis is less than that causing a paralysis 
~ 
which was not quite so severe. On the other hand, perhaps the combination 
of a quite high level of serotonin with suitable changes in the other amine 
levels may account for the effect seen. In this experiment the pronounced 
60 
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excitation occurred when both NE and DA were low. Such an effect would 
not be expected if low NE caused sedation as discussed in Exp. VII and VIII. 
This indicates that brain NE levels are not a reliable index of excitement 
as was postulated previously in this series of experiments unless, of 
I . 
course, the high 5HT counteracted the sedating effect of law NE and DA. 
The paralysis seen in this experiment will be discussed in a following 
section (Chapter V). 
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Experiment X 
DOSAGE AND DRUGS 
~MPT 80 mg/kg. 5HTP 100 mg/kg 
.>-MPT: TID q 4 hours for one day and one boor before experiment. 
5HTP 15 minutes before experiment. 
DA 
- 95 
NE - 85 
E - 2 
5HT + 220 
Chart 10 
Biogenic Amine Levels 
'7. change from controls 
P.<.01 
P.<.01 
not sig. 
P.<.01 
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Experiment X 
CCl1PARISON WITH CONTROL "CITY" EXPERIMENTS 
IRA ITS NUMERICAL INDEX 
CONTROL DRUGGED 
Exploration decreased 7,0 ± .8 4.0 ± .3 
Digging stayed the same 0.3 ± .3 0.2 ± .1 
Stereot:rpic Behavior stayed the same 0.1 ± .1 0.1 ± .1 
Sleeping increased 2.0 ± .1 4.0 ± .4 
Freezing stayed the same 0.1 ± .1 0.1 ± .1 
Contactual Behavior increased 0.1 ± .2 1.0 ± .5 
Ingestion decreased 0.5 ± .3 0.4 ± .1 
Sexual Behavior stayed the same o.o 0.0 
Grooming Self decreased 2.0 ± •. 2 o.o 
Being Groomed decreased 0.2 ±. .2 0.0 
Grooming Other decreased 0.5 ± .3 o.o 
Aggression decreased 1.5 ± .4 0.0 
Chart lOa 
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Experiment ~ 
All of the animals were very tranquil and quiet during this series 
of experiments. 'l11.ey assumed a resting-sleeping position throughout most 
of the "city" runs. '11te animals were not different from control mice ex-
~1 cept for the .-..MPT effect described earlier; (writhing, ventral wetting and 
,, 
depression). . No ataxia was observed during. the ·"city" study. 
Biochemically, 5HT was increased and all amines decreased. 'l11.e animals 
slept for most of the experiment and behaved similar to those animals 
givenJ...MPT alone (Exp. VII) although sleeping was less in this series. 
'l11.e sleeping behavior seen in this experiment will be discussed in 
Chapter V. 
.. 
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I Experiment XI 
Pargyline 100 mg/kg, J.-MPI' 80 mg/kg. L-Dopa 50 mg/kg. 
Pargyline 25 hours before experiment. 
J....MPI' TID q 4 hours for one day and one hour before experiment. 
L-Dopa 15 minutes before experiment 
Biogenic Amine Levels 
% change from control 
DA + 20 P.<.01 
NE + 60 P.<.01 
E + 2 not sig. 
5HT + 300 P.<.01 
Chart 11 
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Experiment XI 
CCMPARISON WI'lll CONTROL "CITY" EXPERIMENTS 
TRAITS NUMERICAL INDEX 
CCl!ITR.OL DRUGGED 
Exploration decreased ?.o ± .a 1.0 ± .4 
Digging decreased 0.3 ± .3 0.2 ± .1 
StereotyPic Behavior decreased 0.1 ± .1 0.0 
Sleeping decreased 2.0 ± .1 o.o 
Freezing decreased 0.1 ± .2 0.0 
Contactual Behavior decreased 0.1 ± .1 . 0.0 
Ingestion decreased 0.5 ± .3 o.o 
Sexual Behavior decreased o.o 0.0 
Grooming §.£!! decreas~d 2.0 ± :2 0.0 
Being Groomed decreased 0.2 :I: .2 o.o 
Grooming other decreased 0.5 ± .3 0.0 
Aggression decreased 1.5 ± .4 0.0 I Catatonia increased 0.0 10.0 ± .3 I 
Chart lla 
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Experiment XI 
I 
All of the animals assumed a catatonic state after the injection of 
L-Dopa and this accounts for the behavioral deficit. When placed in the 
"city" they would hold the position in which they were placed. After the 
first forty-five (45) minutes the animals began to walk and assume different 
positions which they would then hold for long periods of time. Pilo-
erection was noticed during the first fifteen (15) minutes. Body temper-
ature was normal. The animals moved slowly with no ataxia. 
No amine in. this experiment exceeded levels which in other experi-
ments were correlated with toxic effects. However catatonia was observed. 
Therefore the catatonia is possibly not due to amine levels but some other 
direct action of L-Dopa on the CNS. 
r 
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Experiment XII 
DOSAGE AND DRUGS 
J.MP'f 80 mg/kg. L-Dopa 50 mg/kg. 
PT - TID q 4 hours for one day and one hour before experiment. 
L-Dopa - 15 minutes before experiment. 
Biogenic Amine Levels 
% change from control 
Ill\ - 20 p .<. 01 
NE 25 P.<.01 
E - 6 not sig. 
5HT + 2 not sig. 
~ Chart 12 
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Experiment XII 
CCMPARISON WITH CONTROL "CITY" EXPERIMENTS 
TRAIT NUMERICAL INDEX 
CONTROL DRUGGED 
Exploration decreased 7.0 :I: .8 1.0 ± .1 
Digging decreased 0.3 ± .3 o.o 
Stereot;ypic Behavior 0.1 ± .1 o.o 
Sleeping increased 2.0 :I: .1 8.0 ± .3 
Freezing decreased 0.1 ± .2 o.o 
Contactual Behavior increased 0.1 ± .1 1.0 ± .2 
!ngestion stayed the same 0.5 :I: .3 0.4 :I: .1 
Sexual. Behavior stayed the same o.o o.o 
Grooming Self decreased 2.0 :I: .2 0.0 
Being Groomed decreased 0.2 :I: .2 o.o 
Grooming Other decreased 0.5 :I: .3 0.0 
Aggression decreased 1.5 :I: .4 o.o 
Chart 12a 
' 
69 
1 
r 
Experiment XII 
All animals slept for most of this experiment. They were moving 
slowly, but were not in a catatonic state. No ataxia was observed. The 
animals were wet ventrally when placed in the chamber, but body temperature 
was normal (42 degrees C) for this strain. A viscous substance, appeared 
around the genitalia. No piloerection or shaking was observed. 
Biochemically a NE and DA. decrease was seen. Sleeping may hav~ been 
due to the low norepinephrine. It is interesting to note that the direct 
effect of L-Dopa (described earlier) relating to catatonia was not seen. 
This may have been due to the low norepinephrine or due to some other 
effect of~MPT which blocked the L-Dopa effect. L-Dopa clearly had a 
pronounced catatonic effect when used with Pargyline with or withoutcia.MPT 
(Exp. IV and XI respectively) and when used in the same dose alone. The 
catatonia seen after L-Dopa administration was prevented by~MPT when no 
monoamine oxidase inhibitor was given seemingly.irrespective of amine or 
5HT levels. 
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Experiment XIII 
DOSAGE AND DRUGS 
CPlO 316 mg/kg. 
CPlO daily for four consecutive days. 
Ill\ - 5 
NE 
- 3 
E - 1 
5HT - 60 
Chart 13 
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Biogenic Amine Levels 
% change from controls 
not sig. 
not sig. 
not sig. 
P.<.01 
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Experiment XIII 
COMPARISON WITH CONTROL "CITY" EXPER.lMENTS 
TRAITS NUMERICAL INDEX 
CONTROL DRUGGED 
Explorati on decreased 1 .. 0 ± .8 4.o·± .3 
Digging de creased 0.3 ± .3 o.o 
Stereot:ypi c Behavior decreased 0.1 ± .1 0.0 
Sleeping r emained same 2.0 ± .1 2.0 ± .2 
Freezing d ecreased 0.1 ± .2 0.0 
Contactual Behavior increased 0.1 ± .1 0.2 ± .1 
Ingestion increased 0.5 ± .3 4.0 ± .4 
Sexual Beh avior remained the same o.o 0.0 
Grooming S elf decreased 2.0 ± .2 1.0 ± .1 
Being Gro omed decreased 0.2 ±. .2 o.o 
.. 
Grooming Other decreased 0.5 ± .3 0.0 
Aggression remained the same 1.5 ± .4 1.5 ± .6 
~art 13a 
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' ' Experiment XIII 
I f The animals were depressed throughout the experiment. No ataxia was 
lnoticed. No piloerection or shaking occurred. Body temperature was nor-
mal (42 degrees C) for this strain. 
5HT level decreased markedly, as expected. A correlation between 
,5HT and sleep is discussed in a following section (Chapter V). 
I One specific and interesting finding is the great increase in ingestive 
behavior. Eating has been related to brain norepinephrine stimulation; 
drinking to a cholinergic system (Miller, 1965). CP-10 did not increase 
any of the adrenergic or serotonergic transmitters but it did increase 
appetitive behavior. It must be presumed that the increased ingestion was 
not the result of a change in amine level by CP-10, but rather it is a 
direct drug effect. 
CP-10 has been reported to facilitate sexual·mounting behavior in 
rats and .rabbits (Tagliamonte et al., 1969; Ferguson et al., 1970). These 
studies indicated that CP-10 may heighten homosexual mounting behavior. 
Later studies showed however that CP-10 would not heighten male-female_ 
sexual mounting and may alter the males ability to distinguish appropriate 
sexual partners (Whalen and Luttage, 1970). Our data do not substantiate 
facilitation of homosexual behavtor in male mice. 
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Experiment XIV 
DOSAGES AND DRUGS 
CPlO 316 mg/kg. ;..MPT 80 mg/kg 
CPlO daily for four consecutive days. 
- TID q 4 hours for one day and one hour before experiment. 
Biogenic Amine Levels 
% Change from Controls 
DA - 99 P.<.01 
NE - 95 P.<.01 
E - 10 not sig. 
SHT - 60 P.<.01 
~Chart 14 
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Experiment XIV 
CCM.PARISON WITH CONTROL "CITY'' EXPERIMENTS 
TRAITS NUMERICAL INDEX 
COOTROL DRUGGED 
Exploration decreased 7·.0 ± .8 4.0 ± .3 
Digging decreased 0.3 ± .3 0.0 
Stereotzyic Behavior decreased 0.1 ± .1 o.o 
Sleeping increased 2.0 ± .1 9.0 ± .2 
Freezing decreased 0.1 ± .2 o.o 
Contactual Behavior decreased 0.1 ± .1 0.0 
Ingestion increased 0.5 ± .3 3.0 ± .9 
Sexual Behavior remained the same o.o 0.0 
IGrooming Self decreased 2.0 ± .2 0.0 
Being Gr?Ollled decreased 0.2 ± .2 0.0 
Grooming Other decreased 0.5 ± .3 o.o 
Aggression decreased 1.5 ± .4 o.o 
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' Experiment XIV 
j All of the animals were depressed throughout the experiment. ntere 
iwas much sleeping and ingestion. Piloerection was noticed in 50% of the 
animals for the first half-hour of the experiment. No ataxia was noticed. 
All of the animals were wet ventrally and a viscous substance much thicker 
than urine was noticed surrounding the genitalia. Body temperature was 
'normal (42 degrees C) fo~ this strain. 
· Many of the effects·, described in earlier experiments, the increased 
I 
I 
appetite, the ventral wetting, increased sleeping and depression, were 
seen in this experiment. nie ventral wetting and genital substance may 
be caused by J.,MPT, the high ingestion may be related to CP-10, the cause 
of sleeping and depression is obscure, and will be discussed in a following 
section (Chapter V). 
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Experiment XV 
DOSAGES AND DRUGS 
CPlO 316 mg/kg, Pargyline 100 mg/kg. 5HT 100 mg/kg. 
ie--MPT 80 mg/kg 
CPlO: daily for four consecutive days 
Pargyline: 24 hours before experiment 
5HTP: 15 minutes before experiment 
~MPT: TID q 4 hours for one day and one hour before experiment 
Biogenic Amine Levels 
% Change from controls 
DA 
- 95 p .<. 01 
NE 
- 99 P.<.01 
E 
- 4 not sig. 
SHT + 226 P.<.001 
Chart 15 
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Experiment XV 
I 
COMPARISON WITH COOTROL "CITY" EXPERIMENTS 
I TRAITS NUMERICAL INDEX 
I 
IExploration decreased 
CONTROL DRUGGED 
7.0 ± .8 0.0 
Digging decreased 0.3 ± .3 0.0 I 
StereotyPic Behavior decreased 0.1 ± .1 0.0 
SleeEing decreased 2.0 ± .1 0.0 
Freezing decreased 0.1 ± .2 o.o l 
I 
Contactual Behavior decreased 0.1 ± .1 o.o 
· Ingestion decreased 0.5 ± .3 0.1 
Sexual Behavior stayed the same o.o 0.0 
Grooming Self decreased 2.0 ± .2 0.0 
Being Groomed decreased 0.2 ± .2 o.o 
Grooming Other decreased 0.5 ± .3 o.o 
I Aggression decreased 1.5 ± .4 0.0 
I 
l 
! 
Chart 15a 
( 
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Experiment XV 
All animals were paralyzed in their hindlimbs. Both forelimbs and 
hindlimbs were abducted in a "spread eagle" fashion. All animals were 
extremely irritable and excited. There appeared quick, jerky movements 
of the head accompanied by constant sniffing of the ground. Piloerection 
was noticed in all animals. The animals seemed to rotate on their hind-
limbs and had respiration problems characterized by hacking and irregular 
breathing. The animals were dry ventrally. Body temperature was normal 
(42 degrees C) for this strain. 
Excitement and strong activity is present although the NE level is 
quite low: the abduction presumed on occasion related to serotonin is 
present although serotonin is lower than levels which do !!2! ~ it in 
other experiments. The relationship between the paralysis seen in this 
experiment and the pattern of amines and serotonin is discussed in the 
· following chapter (Chapter V). 
Chapter V 
GENERAL DISCUSSION 
I In this study there are three behavioral states which need further 
tclarification and sunnnary. These behavioral states are catatonia, 
lparalysis and sleeping. Because of the large amount of data the behavioral 
f and biochemical results will be presented together on three tables. I Table III shows the drugs used, the amine concentration expressed 
as percent change from control, and one of the quantitated behavioral 
traits expressed as the average number of checks per experiment per mouse . 
. It can be seen from Table III that the administration of L-Dopa alone 
resulted biochemically in a significant increase in DA and NE. As indicated 
in the results section the animals were in a state of catatonia, i.e. 
(the animals assumed a rigid position and would not move) for an average 
of 10 out of 15 checks, This behavior is absent in the control animals. 
Administration of Pargyline alone resulted in an increase in DA, NE and 
SHT in excess of that seen when L-Dopa alone was administered, yet no 
catatonia was seen. Perhaps the increase in SHT seen after administration 
of Pargyline alone may have counteracted the catatonia resulting from 
the administration of L-Dopa alone. However, after the administration 
of Pargyline and Dopa together an increase in Ill\, NE, and SHT resulted .. 
which was greater than that seen from either drug alone, yet the animals 
were again in a state of catatonia similar to the animals which had re-
ceived L-Dopa alone. A 5HT increase had no counteracting effect. There 
seems to be no proof that the amines are modulating this catatonia for 
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TABLE III 
TABLE IV 
TABLE V 
Effect of Drugs on DA, NE and SHT Levels 
and Catatonia. 
Effect of Drugs on DA, NE and SHT Levels 
and Paralysis. 
Effect of Drugs on DA, NE and SHT Levels 
and Sleep. 
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nowhere in our data do we find this behavioral state without the admin-
istration of Pargyline and 9HTP resulted in an increase in DA, NE and 
5HT in a manner quite similar to the catatonia producing drugs, yet no 
catatonia was seen. Yet catatonia was seen after the administration of 
Pargyline, J..MPT and L-Dopa, and here the amine levels are similar to 
those levels which did not cause catatonia. Perhaps catatonia was due 
to an effect of the drug, L-Dopa on the central nervous system (CNS) of 
the animals. However, no catatonia was seen whe~ L-Dopa was administered 
with ..lMPT. Here, however, the amines are very low. It seems, therefore, 
that L-Dopa has an effect of its own on the CNS: it has such an effect 
only when the amines are at a high optinum level. 
Table IV shows that there was a significant increase in SHT after the 
administration of 5HTP. The change in DA and NE, however, was not signifi-
cant after this drug. DA, NE and 5HT were all significantly increased 
after the administration of Pargyline. The behavior of the animals re-
ceiving these two drugs alone was in no way different from the behavior 
of the saline control animals (Exps. III, V). However, all the animals 
receiving t~ese two drugs together (Pargyline and 5HTP) exhibi~ed a tremor 
of the head and forepaws as described in the results section. The animals 
lay in a "spread eagle" fashion for most of the experiment. Although the 
levels of DA, NE and 5HT are al~ increased with this combination, the 
increase in 5HT is greater than that produced by 5HTP or Pargyline alone. 
A tremor and paralysis was also produced as a result of the administration 
of Pargyline, J..MPT and 5HTP together. However, the DA and NE levels were 
reduced whereas the 5HT level was increased to 400% of control. It could 
82 
be assumed at this point that the extremely high levels of 5HT (425% 
of control in the first case and 400% of control in the second) may be 
implicated as a causal factors in the paralysis. However, subsequent 
experiments reveal a similar change in amines after administration of 
Pargyline andJ..MPT. In this case, however, no tremor or paralysis was 
seen although there was an increase in 5HT to 380% of the control value, 
and the levels pf NE and DA are very similar to those levels which were 
accompanied by the paralysis. 
It may be that 5HTP is exerting a direct effect to cause the paralysis. 
It has this effect only when the level of 5HT is at a critical level. 
Table V shows that after the administration of d...MPT, the animals 
suffered a significant loss of NE and DA. 5HT in this experiment was not 
affected. Behaviorally the animals slept for an average of 10 out of 
15 checks. The control value for sleeping is two out of a total of fifteen 
checks. 
Per~aps low NE and DA was responsible for the sleep producing effect 
of J..MPT. Branchey (1970) found that a single intraperitoneal injection 
of 200 mg/kg d-alpha-methyl-para-tyrosine in the rat induced a significant 
increase in NREM sleep without affecting REM sleep. On the other hand, 
Ban (1969) showed that increased brain levels of DA are associated with 
sedative effects whereas both 04. and 5HT levels were associated with 
hypnotic effects. The two effects may be differentiated by a marked 
increased 5HT level for hypnotic effects and to a lesser extent by in-
creases of DA and NE. 
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' I The effects of administration of Reserpine on NE and DA are well 
lknown, and a direct relationship between low NE and DA levels and the 
f 
'sedative effects of Reserpine is presumed by many authors (Introduction). 
However, because Reserpine also depletes 5HT, controversy has arisen in 
the past over the importance of 5HT and the catecholamines in Reserpine 
induced sedation. However, Reserpine induced sedation without depletion 
of 5HT has been reported by Gal and Millard ·(1967). 
Table III also shows that after the administfation of CPlO alone 
no change from control in sleeping behavior was noticed. DA and NE levels 
were normal, but the 5HT level was decreased after administration of this 
drug. 
After administration of CPlO and .,1..MPT together the animals showed an 
increase in sleeping behavior over the control animals. The drugged 
animals sleJtfor an average of nine out of a total of fifteen checks. 
DA, NE and 5HT were all decreased. So far then the increase in sleeping 
.behavior. occurs whenever there is an accompanying low level of both DI\ 
and NE, regardless of the levels of 5HT. The level of 5HT seems to be 
unimportant .so far, i.e. after administration of J.-MPT alone it was normal 
and after CPlO and J..MPT together it was decreased, yet in both of these 
experiments an increase in sleeping behavior was seen. However, after 
administration of Pargyline and"'-MPT together a decrease in sleeping was 
seen although DI\ and NE levels were again decreased and the 5HT level was 
increased. The administration of Pargyline, CPlO and~ and 5HT to-
gether produced similar changes in amines and sleeping behavior. It 
would seem then that the high 5HT level counteracted the sedating effect 
·-----~------------------------------------------------------------------------" 
I .... , -----
.----..,.,,, ...... ~,.._.,,,, _______________ _ 
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I of low DA. and NE. Hery et al. (1970) found an increased 5HT synthesis I induced by paradoxical sleep deprivation. This seemed to be the result 
of increased uptake of tryptophan as well as increased conversion to 5HT. 
His results supported the hypothesis that serotonergic neurons are in-
volved in paradoxical sleep processes. Delorme et al. (1966) showed that 
chronic serotonin depletion by PCPA (CPlO) is accompanied by a transitory 
insomnia, the emergence of lateral geniculate spikes into wakefulness, and 
global behavioral changes including hypersexuality, irritability, and 
increased aggressiveness. 
Our hypothesis, that the high serotonin counteracted the sedative 
effect of low NE and DA was tenuous because the administration of J..MPT 
and 5HTP produced a change in amines almost exactly the same as that 
produced by Pargyline andd--MPT together. That is, a decrease in NE and 
DA and an increase in 5HT. Sleeping was increased in this case and the 
high 5HT level had no counteracting effect. 
Slee~ing may be due to a direct drug effect·, i.e. J...MPT produces 
sedation except when administered alone with Pargyline. Such a drug inter-
action is the only simple hypothesis this data permits. Low levels of DA 
and NE, then, do not seem to be a reliable index of sedation and sleep as 
postulated earlier. 
Miller (1965) in a preliminary report suggested that the balance of 
free 5HT/NE was the deciding factor in behavioral depression induced by 
the benzoquinolizines. He suggested that the preponderance of free 
5HT/NE resulted in sedation. 
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Chapter VI 
CONCWSIOO 
It is known that microinjection of different drugs in identical brain 
areas will elicit different discrete behavioral acts {Miller, 1965). It 
has also been shown that the drug systematically injected may have a be-
havioral effect opposite to that of a selective placement by microinjection 
in the brain (Gal and Millard, 1967). Our present studies have several 
disadvantages: 1) The drugs are injected systemically and the observed 
changes in amines may differ from fluctuations in amines brought about by 
local injection. 2) The behavioral parameters which were studies are often 
obliterated by the toxic effects of individual drugs. 3) Amine changes in 
brain p•rts were not determined. Indeed, the amine levels are determined 
for whole brain and presumably the biogenic amine levels have changed 
everywhere at varying rates of synthesis or depletion, both bound and un-
bound. Therefore it is still possible, even if.clear cut behavioral modu-
lation is not seen in these experiments that chemical coding of behavior 
exists. Certainly hormonal effects on behavior are well established 
(Miller, 1965) and sintequantitation of mental stress by an analysis of 
urinary catecholamine levels is possible (Von Euler, 1964), there must be 
a close correlation if not a cadsal relationship. 
Behaviorally, in some parameters, widely different chemical agents 
may be similar in effects. Thus atropine and scopolamine, MAO!, pheno-
thiazines, codeine and antihistaminics, may reverse aggressive behavior 
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at low, non-toxic doses (Da Vanzo et al., 1968). It is well known that 
different central acting drugs; bemegride, morphine, alcohol and many 
others show selective action on different centers, circuits, systems or 
cell populations in the brain. There may or may not be a transmitter 
basis for the behavioral effects of these drugs. The effects may be due 
to a change in irritability of certain neurons selectively. 
On the basis of the lack of consistant correlation between amines of 
whole brain and behavior and the great f luctuation'.s of amine levels 
measured in these experiments, it is unlikely that changes in the levels 
of the biogenic amines alone could give much insight on complex mechanisms 
involved in behavior. Whereas the effects of these amines at particular 
sites in the brain probably are of crucial importance in the regulation 
of behavtor, any fornulation of the physiology of behavior would have to 
include other biochemical, physiological and psychological factors. 
Sumnary 
The·(whole mouse brain) levels of norepinephrine, epinephrine, 
serotonin, dopa and dopamine were varied more or less selectively by means 
of suitable injection schedules and combinations of parachlorophenylalanine 
L-Dopa, 5-hydroxytryptophane, pargyline and a-methyl-p-tyrosine. The 
amines and serotonin were extracted and determined spectrophotoflouro-
metrically according to the tecl\nique of Weigand and Perry (Biochem. Pharm .. 
7: 181-6, 1961). The extraction was made at the mid point in time during 
which the behavior of similarly treated animals was quantitated. 
The behavior (of the mice) was quantitated using a "Mouse City" 
set-up made of plexiglass. It is composed of six small home cages 
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(5" x 7" x 4") each connecting with a central conmunal chamber (18" x 
11" x 611 ) by means of funnel-like, cylindrical runways. In the city 
experiment, two aggregated males, after suitable drug pre-treatment, were 
placed in each of the small cages of the "city". The animals were sub-
• 
sequently allowed to freely interact with one another and at five minute 
intervals were checked for the following behavioral parameters: exploration, 
digging, stereotypic behavior, food-carrying-, sexual behavior, fr~ezing, 
sleeping, contactual behavior and aggression. 
No completely satisfactory correlation was found between any single 
amine level or ratio of amine levels and behavior. Three predominant be-
haviors emerged from these studies; catatonia, sleep and paralysis. 
The effect of the drugs on other behaviors is discussed in reference 
to these three behaviors. The effects on behavior seen in these experi-
ments by and large are presumed to be due either to direct drug effects 
or to effects of drugs on other neurohmnors or .systems not measured in 
this study. Catecholamines and Serotonin did not in general prove to be 
reliable indexes of any behavior nor did levels of the amines or serotonin 
give predictable behavioral responses. 
The work presented in this thesis was helpful in clearing the way for 
a better understanding of which behaviors and what aspects of brain function 
are regulated by the neurohumors~and although the results are largely neg-
ative they were invaluable for a constructive interpretation in later re-
search for a Doctorate Dissertation. 
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